Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene

Microbiology

Volumn 143, Issue 2, 1997, Pages 405-416

  Sanglard, Dominique ^a   Ischer, Françoise ^a   Monod, Michel ^a   Bille, Jacques ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Azole antifungal agents; Candida albicans; Multidrug efflux transporters

Indexed keywords

ABC TRANSPORTER; ANTIFUNGAL AGENT; GLYCOPROTEIN P; PYRROLE;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA; EFFUSION; GENE; GENE EXPRESSION; GENE LIBRARY; MULTIDRUG RESISTANCE; MUTANT; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

CANDIDA ALBICANS; SACCHAROMYCES CEREVISIAE;

EID: 0031047670     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-143-2-405     Document Type: Article

References (33)

1. Balzi, E., Wang, M., Leterme, S., Van Dyck, L. & Goffeau, A. (1994). PDR5, a novel yeast multidrug resistance transporter controlled by the transcription regulator PDR1. J Biol Chem 269, 2206-2214.
2. Berrouane, Y. F., Mollis, R. J. & Pfaller, M. A. (1996). Strain variation among and antifungal susceptibilities of isolates of Candida krusei. J Clin Microbiol 34, 1856-1858.
3. Bissinger, P. H. & Kuchler, K. (1994). Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. J Biol Chem 269, 4180-4186.
4. Chavanet, P., Lopez, J., Grappin, M., Bonnin, A., Duong, M., Waldner, A., Buisson, M., Camerlynck, P. & Portier, H. (1994). Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro in vivo correlation in HIV-infected patients. AIDS 8, 945-950.
5. Chen, W. & Struhl, K. (1988). Saturation mutagenesis of a yeast his3 "TATA element": genetic evidence for a specific TATA-binding protein. Proc Natl Acad Sci USA 85, 2691-2695.
6. Ehrenhofer, M. A., Wurgler, F. E. & Sengstag, C. (1994). The Saccharomyces cerevisiae SGE1 gene product: a novel drug-resistance protein within the major facilitator superfamily. Mol Gen Genet 244, 287-294.
7. Essayag, S. M., Baily, G. G., Denning, D. W. & Burnie, J. P. (1996). Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua. Int J Syst Bacteriol 46, 35-40.
8. Feinberg, A. & Vogelstein, B. (1984). A technique for radio-labelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 17, 266-267.
9. Fling, M. E., Kopf, J., Tamarkin, A., Gorman, J. A., Smith, H. A. & Koltin, Y. (1991). Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 227, 318-329.
10. Fonzi, W. A. & Irwin, M. Y. (1993). Isogenic strain construction and gene mapping in Candida albicans. Genetics 134, 717-728.
11. v gene. Antimicrob Agents Chemother 39, 422-426.
12. Hanahan, D. (1985). Techniques for transformation of E. coli. In DNA Cloning: a Practical Approach, pp. 109-135. Edited by D. M. Glover. Oxford: IRL Press.
13. Hitchcock, C. A., Pye, G. W., Troke, P. F., Johnson, E. M. & Warnock, D. W. (1993). Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother 37, 1962-1965.
14. Hube, B., Monod, M., Schofield, D. A., Brown, A. J. P. & Gow, N. A. R. (1994). Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol 14, 87-99.
15. Johnson, E. M., Davey, K. G., Szekely, A. & Warnock, D. W. (1995a). Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species. J Antimicrob Chemother 36, 787-793.
16. Johnson, E. M., Warnock, D. W., Luker, J., Porter, S. R. & Scully, C. (1995b). Emergence of azole drug resistance in Candida species fom HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 35, 103-114.
17. Marichal, P. & Vanden Bossche, H. (1995). Mechanisms of resistance to azole antifungals. Acta Biochim Pol 42, 509-516.
18. Monod, M., Togni, G., Hube, B. & Sanglard, D. (1994). Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 13, 357-368.
19. Needleman, S. B. & Wunsch, C. D. (1970). A general method applicable to the search of similarities in the amino acid sequence of two proteins. J Mol Biol 48, 443-453.
20. Odds, F. C. (1996). Resistance of clinically important yeasts to antifungal agents. Int J Antimicrob Agents 6, 145-147.
21. Odds, F. C., Schmid, J. & Soll, D. R. (1990). Epidemiology of Candida infections in AIDS. In Mycoses in AIDS Patients, pp. 67-74. Edited by H. Vanden Bossche, D. W. R. Mackenzie, G. Cauwenberg, J. Van Custem, E. Drouhet & B. Dupont. New York: Plenum Press.
22. Odds, F. C., Dams, G., Just, G. & Lewi, P. (1996). Susceptibilities of Candida spp to antifungal agents visualized by two-dimensional scatterplots of relative growth. Antimicrob Agents Chemother 40, 588-594.
23. Parkinson, T., Falconer, D. J. & Hitchcock, C. A. (1995). Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob Agents Chemother 39, 1696-1699.
24. Powderly, W. G. (1994). Resistant candidiasis. AIDS Res Hum Retroviruses 10, 925-929.
25. Prasad, R., Dewergifosse, P., Goffeau, A. & Balzi, E. (1995). Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27, 320-329.
26. Rex, J. H., Rinaldi, M. G. & Pfaller, M. A. (1995). Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39, 1-8.
27. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M. & Bille, J. (1995). Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39, 2378-2386.
28. Sanglard, D., Ischer, F., Monod, M. & Bille, J. (1996). Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40, 2300-2305.
29. Santos, M. & Tuite, M. F. (1995). The CUG codon is decoded in vivo as serine and not leucine in Candida albicans. Nucleic Acids Res 23, 1481-1486.
30. Vanden Bossche, H., Marichal, P., Odds, F., Lejeune, L. & Coene, M.-C. (1992). Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 36, 2602-2610.
31. Vanden Bossche, H. V., Warnock, D. W., Dupont, B., Kerridge, D., Sengupta, S., Improvisi, L., Marichal, P., Odds, F. C., Provost, F. & Ronin, O. (1994a). Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol 32 (Suppl. 1), 189-202.
32. Vanden Bossche, H., Marichal, P. & Odds, F. C. (1994b). Molecular mechanisms of drug resistance in fungi. Trends Microbiol 2, 393-400.
33. Vuffray, A., Durussel, C., Boerlin, P., Boerlin, P. F., Bille, J., Glauser, M. P. & Chave, J. P. (1994). Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. AIDS 8, 708-709.